Trial reportHaematologica2018
Prognostic factors of Erdheim-Chester disease: a nationwide survey in Japan.
Trial report in Haematologica, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
19 citing papers in PubMed, 34 citations in OpenAlex.
- Dabrafenib plus trametinib in BRAF V600E-mutant Erdheim-Chester disease: a case series including CNS involvement.International journal of hematology · 2026Article
- Article
- Neuroimaging Spectrum of Erdheim-Chester Disease: An Image-Based Review.AJNR. American journal of neuroradiology · 2025Review
- Erdheim-Chester Disease with Pancreatic Enlargement Observed Using Contrast-enhanced Endoscopic Ultrasonography.Internal medicine (Tokyo, Japan) · 2025Article
- Rare severe constrictive pericarditis complication in Erdheim-Chester disease: A case report and literature review.Journal of clinical and experimental hematopathology : JCEH · 2024Review
- The clinical spectrum and prognostic factors of Erdheim-Chester disease and mixed Langerhans cell histiocytosis and Erdheim-Chester disease.Annals of hematology · 2023Article
- Cardiac involvement resolution is frequent and associated with improved outcome in Erdheim-Chester disease.Blood advances · 2023Article
- Article
- Rare Cutaneous Manifestations of Erdheim Chester Disease: A Case Report and Literature Review.Cureus · 2023Article
- Adult onset xanthogranuloma of the eyelid.American journal of ophthalmology case reports · 2023Article
- Erdheim-Chester Disease With BRAF V600E Mutation and Central Diabetes Insipidus Successfully Treated With Glucocorticoid.JCEM case reports · 2023Article
- A long-term survival case of Erdheim-Chester disease on maintenance hemodialysis.CEN case reports · 2022Article
- Pericardial Effusion in Erdheim-Chester Disease: A Case Report and a Mini Literature Review.Cureus · 2022Article
- Article
- Cerebellar ataxia and exercise intolerance in Erdheim-Chester disease.Cerebellum & ataxias · 2021Article
- Neurologic and oncologic features of Erdheim-Chester disease: a 30-patient series.Neuro-oncology · 2020Article
- Erdheim-Chester disease progression from miliary pulmonary nodules to large tumours.Respirology case reports · 2019Article
- Update on the classification of T-cell lymphomas, Hodgkin lymphomas, and histiocytic/dendritic cell neoplasms.Expert review of hematology · 2019Review
- Clinical and positron emission tomography responses to long-term high-dose interferon-α treatment among patients with Erdheim-Chester disease.Orphanet journal of rare diseases · 2019Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
21 authors at 6 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Erdheim-Chester disease is a rare histiocytosis with insufficient clinical data. To clarify the clinical features and prognostic factors of Erdheim-Chester disease, we conducted a nationwide survey to collect the detailed data of 44 patients with Erdheim-Chester disease in Japan. The median age of onset of the participants was 51 (range: 23-76) years, and the median number of involved organs per patient was 4 (range: 1-11). The existence of central nervous system disease was correlated with older age (
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.